Pediatrix Medical Group, Inc. (NYSE:MD) Given Consensus Rating of “Hold” by Analysts

Pediatrix Medical Group, Inc. (NYSE:MD) has earned a consensus rating of “Hold” from the five brokerages that are covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $16.10.

MD has been the topic of several recent research reports. UBS Group raised their price objective on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research note on Tuesday, November 5th. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a report on Monday, November 4th. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday. Jefferies Financial Group lifted their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Finally, Mizuho increased their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th.

Insider Buying and Selling at Pediatrix Medical Group

In related news, Director Mark S. Ordan sold 27,600 shares of the firm’s stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the completion of the transaction, the director now directly owns 138,683 shares of the company’s stock, valued at approximately $2,128,784.05. This trade represents a 16.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO James D. Swift sold 11,100 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $10.79, for a total transaction of $119,769.00. Following the sale, the chief executive officer now directly owns 170,001 shares in the company, valued at approximately $1,834,310.79. The trade was a 6.13 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 53,808 shares of company stock worth $751,277. Insiders own 2.00% of the company’s stock.

Institutional Trading of Pediatrix Medical Group

A number of large investors have recently made changes to their positions in MD. nVerses Capital LLC purchased a new position in Pediatrix Medical Group in the second quarter worth about $31,000. Innealta Capital LLC bought a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at approximately $33,000. Quest Partners LLC raised its holdings in Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after buying an additional 622 shares during the period. Nisa Investment Advisors LLC lifted its position in Pediatrix Medical Group by 47.2% in the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock worth $36,000 after buying an additional 1,524 shares during the last quarter. Finally, Quarry LP boosted its stake in Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after buying an additional 1,662 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Price Performance

NYSE MD opened at $14.15 on Monday. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of -4.62, a PEG ratio of 2.18 and a beta of 1.55. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. The business’s fifty day moving average price is $12.53 and its 200-day moving average price is $9.84. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $16.41.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. The company had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.29 earnings per share. On average, equities analysts predict that Pediatrix Medical Group will post 1.25 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.